Introduction Aggressive variants of papillary thyroid cancer (PTC) have been described with
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …

Advances in medical sciences and evidence-based medicine have led to momentous
changes in classification and management of thyroid neoplasms. Much progress has been …

Background The association between telomerase reverse transcriptase (TERT) promoter
mutations and some clinical behaviors in thyroid cancer remains controversial and requires …

Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC)
have been performed before the 2017 World Health Organization (WHO) classification, in …

This review addresses the impact of molecular alterations on the diagnosis and prognosis of
differentiated thyroid carcinoma (DTC), including papillary, follicular, and well-differentiated …

Simple Summary Aggressive variants of papillary thyroid carcinoma (PTC) are associated
with unfavorable clinical outcomes. However, limited data exist on the genetic profile of …

Context Recent diagnostic criteria updates of the tall cell variant of papillary thyroid
carcinoma (TCPTC) by the World Health Organization (WHO) have determined the inclusion …

Simple Summary This study evaluated the need for additional surgical treatment in patients
diagnosed with aggressive variants of papillary thyroid cancer after lobectomy. With the …

Papillary thyroid carcinoma tall cell variant (PTC‐TCV), a form of PTC regarded as an
aggressive subtype, shares several morphologic features with oncocytic tumors. Pathogenic …

Tall cell papillary thyroid carcinoma (TC-PTC) is considered adverse histology. However,
previous studies are confounded by inconsistent criteria and strong associations with other …